Search research articles
Contact Us
Filters
Showing results (61-70 of 269) with videos related to
Page
of 27
Sort By:
BMJ Case Reports
|
October 11, 2012
A classic case of amyloid cardiomyopathy
Hayan Jouni, William G Morice, S Vincent Rajkumar, et al.
Journal of the American College of Cardiology
|
May 24, 2008
Potential role of the ubiquitin-proteasome system in atherosclerosis: aspects of a protein quality disease
Joerg Herrmann, Sandra M Soares, Lilach O Lerman, et al.
European Heart Journal
|
March 10, 2007
Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
Amir Lerman, David R Holmes, Joerg Herrmann, et al.
European Heart Journal
|
March 8, 2022
Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies
Matthias Totzeck, Lars Michel, Yi Lin, et al.
JACC. Cardiovascular Interventions
|
August 20, 2021
Reply: Cancer Patient Risk After Coronary Intervention: Words of Caution in Complicated Patients
Joerg Herrmann, Wei Guo, Ximin Fan, et al.
Mayo Clinic Proceedings
|
February 3, 2024
Cardiotoxicity Risk of Cancer Treatment in Patients With Underlying Cardiomyopathies: Is Hypertrophic Cardiomyopathy Any Different?
Muhannad Aboud Abbasi, Edward El-Am, Jeffrey B Geske, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 24, 2006
Angiogenesis in atherogenesis
Joerg Herrmann, Lilach O Lerman, Debabrata Mukhopadhyay, et al.
Progress in Molecular Biology and Translational Science
|
June 26, 2012
The ubiquitin-proteasome system and cardiovascular disease
Saul R Powell, Joerg Herrmann, Amir Lerman, et al.
Science Bulletin
|
February 27, 2025
New insights into therapeutic strategies, drugs, and targets for advancing cancer therapy-related cardiovascular toxicity
Yong Wang, Weili Li, Chun Li, et al.
JACC. Case Reports
|
January 21, 2026
Cyclophosphamide-Induced Hemorrhagic Myocarditis
Rade R Jibawi Rivera, David M Harmon, Joerg Herrmann, et al.
Page
of 27
Search research articles
Search
Showing results (61-70 of 269) with videos related to
Sort By:
Page
of 27
BMJ Case Reports
|
October 11, 2012
A classic case of amyloid cardiomyopathy
Hayan Jouni, William G Morice, S Vincent Rajkumar, et al.
Journal of the American College of Cardiology
|
May 24, 2008
Potential role of the ubiquitin-proteasome system in atherosclerosis: aspects of a protein quality disease
Joerg Herrmann, Sandra M Soares, Lilach O Lerman, et al.
European Heart Journal
|
March 10, 2007
Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
Amir Lerman, David R Holmes, Joerg Herrmann, et al.
European Heart Journal
|
March 8, 2022
Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignancies
Matthias Totzeck, Lars Michel, Yi Lin, et al.
JACC. Cardiovascular Interventions
|
August 20, 2021
Reply: Cancer Patient Risk After Coronary Intervention: Words of Caution in Complicated Patients
Joerg Herrmann, Wei Guo, Ximin Fan, et al.
Mayo Clinic Proceedings
|
February 3, 2024
Cardiotoxicity Risk of Cancer Treatment in Patients With Underlying Cardiomyopathies: Is Hypertrophic Cardiomyopathy Any Different?
Muhannad Aboud Abbasi, Edward El-Am, Jeffrey B Geske, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 24, 2006
Angiogenesis in atherogenesis
Joerg Herrmann, Lilach O Lerman, Debabrata Mukhopadhyay, et al.
Progress in Molecular Biology and Translational Science
|
June 26, 2012
The ubiquitin-proteasome system and cardiovascular disease
Saul R Powell, Joerg Herrmann, Amir Lerman, et al.
Science Bulletin
|
February 27, 2025
New insights into therapeutic strategies, drugs, and targets for advancing cancer therapy-related cardiovascular toxicity
Yong Wang, Weili Li, Chun Li, et al.
JACC. Case Reports
|
January 21, 2026
Cyclophosphamide-Induced Hemorrhagic Myocarditis
Rade R Jibawi Rivera, David M Harmon, Joerg Herrmann, et al.
Page
of 27